[1]
M. Kaplan, “Efficacy and safety of single high-dose versus double high-dose intracoronary bolus tirofiban in patients with ST-segment elevation myocardial infarction”, Eur Res J, vol. 7, no. 1, pp. 12–21, Jan. 2021, doi: 10.18621/eurj.560531.